|Day Low/High||106.80 / 107.87|
|52 Wk Low/High||81.22 / 114.26|
Stocks hold onto gains through the morning session as new home sales hit a nearly eight-year high in July.
Stocks hold onto solid gains by mid-morning Tuesday after new home sales hit an eight-year high.
U.S. futures were rising across the board on Tuesday while crude prices experienced a decline.
Monsanto (MON) and suitor Bayer (BAYRY) are said to be moving closer to an agreement as talks advance.
Pfizer finalizes a deal to buy cancer drugmaker Medivation; ChemChina gets U.S. approval for its takeover of Syngenta; Viacom CEO Philippe Dauman is ousted.
The two companies are still working with anti-trust regulators on the $44.7 billion deal.
Monsanto (MON) has reportedly given German suitor Bayer (BAYRY) limited access to its books after the U.S. seeds company rejected its sweetened $64 billion takeover bid last month.
During Monsanto Company's (NYSE: MON) eighth Whistle Stop tour event for investors, chairman and chief executive officer Hugh Grant and other members of the Monsanto executive leadership team will highlight how the...
Monsanto (MON) plans to broaden its computerized farming subsidiary, which delivers weather and planting advice to farmers.
Doug Kass shares his thoughts on his mancrush for Twitter, and why he's buying Macy's.
Monsanto Company (NYSE: MON) announced today that its Board of Directors declared a quarterly dividend on its common stock of 54 cents per share.
Monsanto Company (NYSE: MON) announced it will hold a webcast in conjunction with its eighth Whistle Stop tour investor event scheduled for Wednesday, August 17 and Thursday, August 18 in St.
What's needed after Great Britain's decision to leave the European Union is a bold and daring approach, just like the brave and swashbuckling Brits of yore were famous for.
Monsanto (MON) stock is rising in mid-afternoon trading today as Bayer (BAYRY) is reportedly considering a higher takeover offer for the company.
TheStreet highlights 3 stocks pushing the chemicals industry lower today.
Good pharmaceuticals results mask weak crop science results that could be used to justify a new run at Monsanto.
Overall revenue for the Monsanto bidder falls short of expectations.
The German chemicals company sticks with its forecast for a slight fall in full-year operating profit and a significant decline in sales.
TheStreet highlights 3 stocks pushing the chemicals industry higher today.
Monsanto (MON) stock is reacting favorably to the European Commission's import approval of new genetically modified soybeans for food and livestock feed.
Monsanto Company (NYSE: MON) announced today that the European Commission has granted import approval for Roundup Ready 2 Xtend ® soybeans.
Results from the ChemChina bid target come on the heels of disappointing figures from former suitor Monsanto.
Cramer says he's frustrated with Synergy Pharmaceuticals' situation.
The higher the market goes, so, too, will your risks, Cramer says.
It was the tale of two earnings seasons on Tuesday and Wall Street was stuck in the middle.
Stocks fluctuate late Tuesday as earnings reports are mixed.
Aetna and Humana each traded down sharply as antitrust hurdles may block $34 billion merger.